HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Fills Consumer Chief Post, Promotes Likely CEO Candidates

This article was originally published in The Tan Sheet

Executive Summary

In a slew of appointments, Johnson & Johnson names a successor for Colleen Goggins as worldwide consumer group chairman and positions two senior executives as likely candidates to be the next CEO.

You may also be interested in...



Rolaids Recall Roils McNeil As Year Of OTC Manufacturing Errors Winds Down

McNeil Consumer Healthcare ends 2010 much as it began the year: recalling an OTC product potentially contaminated by a third party – Rolaids Softchews in this case.

J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon

Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.

People In Brief

J&J names McCoy worldwide pharma head: Sheri McCoy is worldwide chairman of Johnson & Johnson's Pharmaceuticals Group, effective Jan. 1, 2009, filling the opening left by Christine Poon's retirement (1"The Tan Sheet" Sept. 15, 2008, p. 11). The New Brunswick, N.J.-based firm says Alex Gorsky will succeed McCoy as worldwide chairman of its Surgical Care Group, and also join the executive committee. Gorsky is currently the company group chairman and worldwide franchise chairman at J&J franchise Ethicon, Inc. "Sheri and Alex are proven leaders in driving high performance and developing talent across multiple business segments," says J&J CEO Bill Weldon

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel